At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 121 enrolled
Drug / intervention
OPA-15406 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2 Multi-center, Randomized, Double-blind, Vehicle-controlled, Three-arm, Parallel Group Study to Assess the Safety, Tolerability, and Efficacy of Topical OPA-15406 Ointment, in Subjects With Mild/Moderate Atopic Dermatitis
Otsuka Pharmaceutical Development & Commercialization, Inc.·interventional·Posted Feb 21, 2014·Updated Nov 23, 2021
In Brief
A Phase 2 clinical trial evaluating OPA-15406 and Vehicle ointment for Atopic Dermatitis. Completed, enrolled 121 participants across 30 sites in 3 countries.
Detailed Summary
The purpose of this study is to investigate the effectiveness and safety of 2 concentrations of OPA-15406 compared to vehicle in participants with atopic dermatitis (AD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesAustralia, Poland, United States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 2014
Enrollment StartJun 2014
Primary CompletionJan 2015
Study CompletionFeb 2015
TodayJul 2026
First PostedFeb 21, 2014
Enrollment StartJun 20, 2014
Primary CompletionJan 28, 2015
Study CompletionFeb 3, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.4 years ago
Interventions
OPA-15406drug
OPA-15406 topical ointment
Vehicle ointmentdrug
OPA-15406 1%-matching placebo topical ointment